Mahasti Saghatchian Curriculum Vitae and Publications - OECI

SAGHATCHIAN Mahasti, Dr
Chairwoman OECI Accreditation Group
OECI Board member
Education
• Degrees:
Medical prize
Master's degree in biological and medical sciences
• Specialization:
Medical Doctoral Thesis specialist in medical oncology
Post-graduate diploma (DEA) in fundamental and applied immunology
University Diploma in Cellular Therapy
Professional Experience (function and hospital/University etc)
• February 2003 – until now: Institut Gustave Roussy, Villejuif, France
- Medical Oncologist, Breast Cancer Unit
- Executive in charge of European and International Affairs
• November 2000 – 2002: Assistant Professor, Oncology, HEGP, Paris, France
Special Recognition
• Main areas of research interest:
Breast cancer molecular prognostic and predictive factors
Organisation of research and care in Europe
• Teaching:
Medical Oncology fellowship training at Institut Gustave Roussy
Clinical and biological courses in Breast cancer at international conferences
• Awards:
ASCO Merit Awards
Laureate of Necker Medical School at University of Paris V, 1995
• Positions held in Cancer Organisation
- Scientific Coordinator of the European project Eurocan + Plus (Feasibility Study for
Coordination of National Cancer Research Activities) 6 th FP
- Member of the Steering Committee, Executive Committee and Biotechnology
Committee of the European consortium TRANSBIG, 6 th FP
- February 2004 – October 2005: Scientific Coordinator of the National Organising
Committee of ECCO 13 (European Cancer Conference) for the Federation of European
Cancer Societies (FECS).
- Member of the American Society of Clinical Oncology (ASCO), of the European
Society for Medical Oncology (ESMO), and member of the Breast Group of the
European Organisation for Research and Treatment for Cancer (EORTC).
• Publications: Attached list

English Peer reviewed Publications:
Serfass L, Van Herpen C, Saghatchian M
Cancer control in Africa
Eur J Cancer .2007 Jul ; (10):1493-5
Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, Haibe-Kains B, Viale G, Delorenzi M, Zhang
Y, d’Assignies MS, Bergh J, Lidereau R, Ellis P, Harris AL, Klijn JG, Foekens JA, Cardoso F,
Piccart MJ, Buyse M, Sotiriou C; TRANSBIG Consortium
Strong time-dependency of the 76-gene prognostic signature for node-negative breast cancer
patients in the TRANSBIG multicentrer independent validation series.
Clinical Cancer Research, 2007 Jun 1; 13 (11):3207-14
Ach RA, Floore A, Curry B, Lazar V, Glas AM, Pover R, Tsalenko A, Ripoche H, Cardoso F,
d’Assignies MS, Laurakay Bruhn, and Laura J. Van ’t Veer
Robust Interlaboratory Reproducibility of a Gene Expression Signature Measurement
Consistent with the Needs of a New Generation of Diagnostic Tools.
BMC Genomics, 2007 Jun 7;8:148.
Buyse M, Loi S, van’t Veer L, Viale G, Delorenzi M, Glas A, Saghatchian M, Bergh J, Lidereau R,
Ellis P, Harris A, Bogaerts J, Therasse P, Floore A, Amakrane M, Piette F, Rutgers E, Sotiriou C,
Cardoso F, Piccart M; TRANSBIG consortium.
Validation and clinical utility of a 70-gene prognostic signature for woman with node negative
breast cancer.
J Natl Cancer Inst, 2006 Sep 6;98(17):1183-92
McCarthy M, Poses RM, Saghatchian M; de Pouvourville G, Tursz T, Gray A
Cancer funding throughout the world.
Lancet Oncol. 2004 Jul; 5(7) 453-7
Saghatchian M, Guepratte S, Hacene K, Neumann R, Floiras JL, Pichon MF.
Serum HER-2 extracellular domain: relationship with clinicobiological presentation and
prognostic value before and after primary treatment in 701 breast cancer patients.
Int J Biol Markers. 2004 Jan-Ma; 19(1): 14-22.
Meunier F, Dubois N, Negrouk A, Rea LA, Saghatchian M, Tursz T, SUlivan R, Law K, Tiner R
Throwing a wrench in the works?
Lancet Oncol. 2003 Dec; 4(12): 717-9
Culine S, Kramar A, Saghatchian M. Bugat R; Lesimple T, Lortholary A, Merrouche Y,
Laplanche A, Fizazi K, French Study Group on Carcinomas of Unknown Primary.
Development and validation of a prognostic model to predict the length of survival in patients
with carcinomas of an unknown primary site.
J Clin Oncol. 2002 Dec 15; 20(24): 4679-83.
Saghatchian M, Fizazi K, Borel C, Ducreux M, Ruffie P, Le Chevalier T, Theodore C.
Carcinoma of an unknown primary site: a chemotherapy strategy based on histological
differentiation – results of a prospective study.
Ann Oncol. 2001 Apr; 12(4): 535-40.
Sharshar T, Auriant I, Dorandeu A, Saghatchian M, Belec L, Benyahia B, Mabro M, Raphael JC,
Gajdos P, Delattre JY, Gray F.
Association of herpes simplex virus encephalitis and paraneoplastic encephalitis – a clinicopathological
study.
Ann Pathol. 2000 May; 20(3): 249-52.

Cocea L, De Smet A, Saghatchian M, Fillatreau S, Ferradini L, Schurmans S, Weill JC, Reynaud
CA.
A targeted deletion of a region upstream from the Jkappa cluster impairs kappa chain
rearrangement in cis in mice and in the 103/bcl2 cell line.
J Exp Med. 1999 May 3; 189(9): 1443-50.
French Publications:
Chapitres Cancers bronchiques non à petites cellules et Immunotherapie des cancers
Livre de l’année 1999, 2001, 2002. Ed AREMAS.
Articles de synthèse pour la revue « Cancérologie Aujourd’hui » : (Tumeurs desmoïdes : une
entité étrange et pénétrante, Cytoprotecteurs en cancérologie, Activité des GCSF glycosylés et
non glycosylés) et compte-rendus de l’ASCO pour la revue « La Lettre du Cancérologue »